Regulon: R-2095
Regulons
are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.
Regulon Summary
Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio
, its Regulator
, the Transcriptional Program
that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.
Genes | Cox Hazard Ratio | Regulators | Causal Flows | Transcriptional Programs | Hallmarks |
---|---|---|---|---|---|
5 | -0.444912 | 1 | 0 | Pr-122 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Regulon Genes
List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator
of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.
Entrez ID | EnsEMBL ID | Preferred Name | Uniprot ID |
---|---|---|---|
489 | ENSG00000074370 | ATP2A3 | Q93084 |
2099 | ENSG00000091831 | ESR1 | P03372 |
3594 | ENSG00000096996 | IL12RB1 | P42701 |
4063 | ENSG00000122224 | LY9 | Q9HBG7 |
860 | ENSG00000124813 | RUNX2 | Q13950 |
Regulon Drugs
Name | Approved Symbol | Type | Action Type | Mechanism of Action | Max Trial Phase | Max GBM Phase |
---|---|---|---|---|---|---|
ESTROGENS, ESTERIFIED | ESR2 | Small molecule | AGONIST | Estrogen receptor agonist | 4 | 0 |
ESTRADIOL | ESR1 | Small molecule | AGONIST | Estrogen receptor alpha agonist | 4 | 0 |
ETHINYL ESTRADIOL | ESR1 | Small molecule | AGONIST | Estrogen receptor alpha agonist | 4 | 0 |
DIETHYLSTILBESTROL | ESR1 | Small molecule | AGONIST | Estrogen receptor alpha agonist | 4 | 0 |
CLOMIPHENE CITRATE | ESR1 | Small molecule | MODULATOR | Estrogen receptor alpha modulator | 4 | 0 |
BRILANESTRANT | ESR1 | Small molecule | ANTAGONIST | Estrogen receptor alpha antagonist | 2 | 0 |
LASOFOXIFENE | ESR2 | Small molecule | MODULATOR | Estrogen receptor modulator | 4 | 0 |
BAZEDOXIFENE ACETATE | ESR2 | Small molecule | MODULATOR | Estrogen receptor modulator | 4 | 0 |
ESTRONE SULFURIC ACID | ESR1 | Small molecule | AGONIST | Estrogen receptor alpha agonist | 4 | 0 |
ESTRIOL | ESR2 | Small molecule | MODULATOR | Estrogen receptor modulator | 4 | 0 |
ACOLBIFENE | ESR2 | Small molecule | MODULATOR | Estrogen receptor modulator | 3 | 0 |
CLOMIPHENE | ESR1 | Small molecule | MODULATOR | Estrogen receptor alpha modulator | 4 | 0 |
AMCENESTRANT | ESR1 | Small molecule | DEGRADER | Estrogen receptor alpha degrader | 3 | 0 |
GTX-758 | ESR1 | Small molecule | AGONIST | Estrogen receptor alpha agonist | 2 | 0 |
TAMOXIFEN CITRATE | ESR1 | Small molecule | MODULATOR | Estrogen receptor alpha modulator | 4 | 2 |
SYNTHETIC CONJUGATED ESTROGENS, B | ESR2 | Small molecule | AGONIST | Estrogen receptor agonist | 4 | 0 |
MIPSAGARGIN | ATP2A3 | Small molecule | INHIBITOR | Sarcoplasmic/endoplasmic reticulum calcium ATPase inhibitor | 2 | 2 |
TAMOXIFEN | ESR1 | Small molecule | MODULATOR | Estrogen receptor alpha modulator | 4 | 2 |
OSPEMIFENE | ESR2 | Small molecule | MODULATOR | Estrogen receptor modulator | 4 | 0 |
TOREMIFENE CITRATE | ESR2 | Small molecule | MODULATOR | Estrogen receptor modulator | 4 | 0 |
ESTRADIOL ACETATE | ESR1 | Small molecule | AGONIST | Estrogen receptor alpha agonist | 4 | 0 |
FULVESTRANT | ESR2 | Small molecule | ANTAGONIST | Estrogen receptor antagonist | 4 | 0 |
ESTROGENS, CONJUGATED SYNTHETIC A | ESR2 | Small molecule | AGONIST | Estrogen receptor agonist | 4 | 0 |
ESTROGENS, CONJUGATED | ESR2 | Small molecule | AGONIST | Estrogen receptor agonist | 4 | 0 |
FISPEMIFENE | ESR2 | Small molecule | MODULATOR | Estrogen receptor modulator | 2 | 0 |
POLYESTRADIOL PHOSPHATE | ESR1 | Small molecule | AGONIST | Estrogen receptor alpha agonist | 4 | 0 |
SR16234 | ESR1 | Small molecule | ANTAGONIST | Estrogen receptor alpha antagonist | 2 | 0 |
AFIMOXIFENE | ESRRG | Small molecule | MODULATOR | Estrogen receptor modulator | 3 | 0 |
DIETHYLSTILBESTROL DIPHOSPHATE | ESR2 | Small molecule | AGONIST | Estrogen receptor agonist | 4 | 0 |
BAZEDOXIFENE | ESR2 | Small molecule | MODULATOR | Estrogen receptor modulator | 4 | 0 |
ESTRADIOL VALERATE | ESR1 | Small molecule | AGONIST | Estrogen receptor alpha agonist | 4 | 0 |
ESTRADIOL CYPIONATE | ESR1 | Small molecule | AGONIST | Estrogen receptor alpha agonist | 4 | 0 |
ESTRONE | ESR1 | Small molecule | AGONIST | Estrogen receptor alpha agonist | 4 | 0 |
ESTROPIPATE | ESR1 | Small molecule | AGONIST | Estrogen receptor alpha agonist | 4 | 0 |
ENCLOMIPHENE | ESR1 | Small molecule | MODULATOR | Estrogen receptor alpha modulator | 3 | 0 |
GIREDESTRANT | ESR1 | Small molecule | DEGRADER | Estrogen receptor alpha degrader | 3 | 0 |
TOREMIFENE | ESR2 | Small molecule | MODULATOR | Estrogen receptor modulator | 4 | 0 |
ESTETROL | ESR2 | Small molecule | AGONIST | Estrogen receptor agonist | 4 | 0 |
ELACESTRANT | ESR1 | Small molecule | DEGRADER | Estrogen receptor alpha degrader | 3 | 0 |
ARZOXIFENE | ESR2 | Small molecule | MODULATOR | Estrogen receptor modulator | 3 | 0 |
CAMIZESTRANT | ESR1 | Small molecule | DEGRADER | Estrogen receptor alpha degrader | 3 | 0 |
Causal Flows
Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation
may causally activates or deactivates a downstream regulator
which then might up- or down-regulates a regulon
that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows for Regulon R-2095
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|